Azelnidipine - CAS 123524-52-7
Catalog number: 123524-52-7
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C33H34N4O6
Molecular Weight:
582.65
COA:
Inquire
Targets:
Calcium Channel
Description:
Azelnidipine is a dihydropyridine calcium channel blocker.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
UR-12592
MSDS:
Inquire
1.Crystal engineering approach to produce complex of azelnidipine with maleic acid
Weiguang Lian, Yulong Lin, Min Wang, Caiqin Yang and Jing Wang*. CrystEngComm, 2013, 15, 3885–3891
The PXRD patterns of the azelnidipine–maleic acid system are shown in Fig. 2. When azelnidipine is coground with maleic acid at a molar ratio of 1 : 1 and 1 : 2 for 15 min and 60 min, the obvious halo patterns are observed (Fig. 2e–h), indicating the amorphous phase of the grinding mixture. This result suggests that the azelnidipine : maleic acid ratio of 1 : 1 and 1 : 2 might not be a suitable stoichiometry for the complex formation, even if grinding time is considered to be optimized. Whereas, new obvious PXRD peaks at 2 = 6.3o, 12.6o, 14.5o, 15.5o, 20.1o, 21.5o, 22.6o, and 25.5o were observed for the complex at the azelnidipine : maleic acid molar ratio of 2 : 1 (Fig. 2c and d). Peak positions of those new peaks were apparently different from those of the starting components, suggesting that crystalloid azelnidipine–maleic acid complex was formed by solvent-assisted co-grinding and prolonged grinding time did not induce the disorder of solid into the amorphous phase. The final azelnidipine–maleic acid complex stoichiometry was close to 2 : 1 within the detection limit of PXRD.
2. Iron catalysed cross-couplings of azetidines –application to the formal synthesis of a pharmacologically active molecule
Dixit Parmar, Lena Henkel, Josef Dib and Magnus Rueping*. Chem. Commun., 2015, 51, 2111—2113
Small nitrogen-containing heterocycles are highly desirable structural motifs, which when installed within molecules can provide beneficial attributes sought after in both the agrochemical and pharmaceutical industries. Within this family, azetidines are particularly interesting units since they possess a reasonable stability whilst providing strong molecular rigidity. Azetidines can be found both in nature and in numerous practical applications with perhaps the highest-profile azetidine being azelnidipine whichissoldasacalciumchannelblocker. Closely related to this, azetidines possessing aryl substitution at the 3-position are highly sought after compounds and have been found to display an array of pharmacological activities.
3. Binding mechanisms of 1,4-dihydropyridine derivatives to L-type calcium channel Cav1.2 a molecular modeling study
Lei Xu, Dan Li, Li Tao, Yanling Yang, Youyong Li and Tingjun Hou*. Mol. BioSyst., 2016, 12, 379—390
In this study, amlodipine, nifedipine and felodipine, three most popular drugs for the treatment of cardiovascular diseases, and the other three drugs, including nimodipine, azelnidipine and benidipine, with different chiral centers and substituents, were chosen as the studied systems. It should be noted that some clinically used DHP derivatives are racemic mixture with chiral centers, but the calcium-channel modulation capability is dependent on the absolute configuration. For example, amlodipine is a racemic mixture containing (R) and (S)-amlodipine isomers in a 1 : 1 ratio, but only (S)-amlodipine has effective therapeutic potency. In order to understand the mechanism of stereoselectivity of enantiomers, the bindings of (R)- and (S)-amlodipines to human Cav1.2 were explored and compared. For the other four DHP derivatives with chiral centers, only the most active isomers were considered. Therefore, in total, seven DHP derivatives were studied here, including (R)-amlodipine, (S)-amlodipine, nifedipine, (S)-nimodipine, (S)-felodipine, (S,S)-azelnidipine and (S,S)-benidipine. First, homology modeling was carried out to construct the 3D model of the central pore region of the a1c subunit of human Cav1.2 based on the crystal structure of the bacterial voltage-gated calcium (Cav) channel. Then, induced fit docking (IFD) was employed to construct the binding structures of the DHP derivatives in complex with Cav1.2. The best complex structure for each DHP derivative predicted by IFD was submitted to 50 ns molecular dynamics (MD) simulations and the binding affinity between each ligand and Cav1.2 was predicted by the Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) approach. We expect that the predicted structures could be useful to design potent and selected ligands of Cav1.2.
4. Fucoidan from Undaria pinnatifida prevents vascular dysfunction through PI3K/Akt/ eNOS-dependent mechanisms in the L-NAME-induced hypertensive rat model
Xiaofei Li, Jian Li, Zhike Li, Hong Ding* and Shanye Yin*. Food Funct.,2016, 7,2398–2408
Calcium channel blockers (CCBs) are a widely utilized first-line antihypertensive agent; representative drugs included nifedipine and azelnidipine. As the primary and clinically effective hypertension therapeutic, CCBs have a number of undesirable pharmacokinetic and pharmacodynamics properties, including first-pass metabolism, short half-life and photodegradation. Moreover, adverse reactions occur frequently, such as nifedipine-induced gingival enlargement as found in recent years. To overcome these disadvantages, new therapeutic targets and corresponding interventions have been designed to address these pharmacodynamic properties (with-drawal reaction and adverse reactions). We therefore investigate whether fucoidan from Undaria pinnatifida could influence NO production in vitro by stimulation of eNOS activation and Akt pathway. We further utilized a rat hypertension model of vascular endothelial injury induced by chronic blockade of nitric oxide (NO) to examine the function of fucoidan treatment in vitro.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Calcium Channel Products


CAS 111470-99-6 Amlodipine Besylate

Amlodipine Besylate
(CAS: 111470-99-6)

Amlodipine Besylate is a long-acting calcium channel blocker, used to lower blood pressure and prevent chest pain.

UK-1745
(CAS: 170684-14-7)

UK-1745, an indole derivative, has been found to be a Calcium channel antagonist that was once studied in the treatment of arrhythmias as well as heart failure.

CAS 1072018-68-8 TTA-P2

TTA-P2
(CAS: 1072018-68-8)

TTA-P2 is a selective T-type calcium channel blocker. It blocks T-type currents with an IC50 of 100 nM and stabilized channel in the inactive state in rats DRGs...

CAS 122647-32-9 Ibutilide Fumarate

Ibutilide Fumarate
(CAS: 122647-32-9)

Ibutilide Fumarate is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset ...

CAS 212778-82-0 Elpetrigine

Elpetrigine
(CAS: 212778-82-0)

Elpetrigine, also known as GW 273293 and JZP-4, has a blocking effect on calcium channels and potassium channels which has been in clinical bipolar disorders an...

CAS 152-11-4 Verapamil HCl

Verapamil HCl
(CAS: 152-11-4)

Verapamil HCl is an L-type calcium channel blocker that is a class IV anti-arrhythmia agent.

CAS 60142-96-3 Gabapentin

Gabapentin
(CAS: 60142-96-3)

Gabapentin is structurally similar to GABA and is reported in various research studies to increase GABA concentrations within the brain. Gabapentin is also note...

CAS 88150-47-4 Amlodipine maleate

Amlodipine maleate
(CAS: 88150-47-4)

Amlodipine maleate is a long-acting dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker). It inhibits the movement of calcium ion...

CAS 136-47-0 Tetracaine Hydrochloride

Tetracaine Hydrochloride
(CAS: 136-47-0)

Tetracaine hydrochlorideis a hydrochloride salt form of tetracaine which is a potent local anaesthetic and a channel function allosteric inhibitor.

CAS 15826-37-6 Disodium Cromoglycate

Disodium Cromoglycate
(CAS: 15826-37-6)

Disodium Cromoglycate is an antiallergic drug with IC50 of 39 μg/mL.

CAS 103890-78-4 Lacidipine

Lacidipine
(CAS: 103890-78-4)

Lacidipine (Lacipil, Motens) is a L-type calcium channel blocker. Lacidipine (Lacipil, Motens) works by relaxing and opening up the blood vessels.

CAS 136941-70-3 Calcium channel-modulator-1

Calcium channel-modulator-1
(CAS: 136941-70-3)

A calcium channel modulator that blocks aortic contraction (IC50= 0.8 μM)

CAS 95635-56-6 Ranolazine 2HCl

Ranolazine 2HCl
(CAS: 95635-56-6)

Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

CAS 79700-61-1 Dopropidil

Dopropidil
(CAS: 79700-61-1)

Dopropidil, also called as ORG 30701, is a cardioactive drug to be classified as a calcium antagonist with combined class I and class VI antiarrhythmic properti...

CAS 91599-74-5 Benidipine HCl

Benidipine HCl
(CAS: 91599-74-5)

Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.

CAS 42399-41-7 Diltiazem

Diltiazem
(CAS: 42399-41-7)

Diltiazem is a nondihydropyridines (non-DHP) calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia as a p...

CAS 63675-72-9 Nisoldipine

Nisoldipine
(CAS: 63675-72-9)

Nisoldipine is a calcium channel blocker, specific for L-type Cav1.2 with IC50 of 10 nM.

CAS 111011-76-8 Efonidipine hydrochloride monoethanolate

Efonidipine hydrochloride monoethanolate
(CAS: 111011-76-8)

The hydrochloride monoethanolate salt form of Efonidipine which has been launched for hypertension and discontinued for cerebrovascular disorders.

Flindokalner
(CAS: 187523-35-9)

Flindokalner, an anxiolytic agent, is a positive modulator at neuronal Kv7 channels and calcium-activated K+ channels (BKCa) in HEK293 cells. Flindokalner can b...

CAS 54527-84-3 Nicardipine Hydrochloride

Nicardipine Hydrochloride
(CAS: 54527-84-3)

Nicardipine is a dihydropyridine calcium-channel blocking agent used for the treatment of vascular disorders.

Chemical Structure

CAS 123524-52-7 Azelnidipine

Quick Inquiry

Verification code

Featured Items